Israeli Pharmaceuticals & Biotech Potentially Undervalued Companies

Teva Pharmaceutical Industries

Market Cap: ₪15.4b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

BioLineRx

Market Cap: ₪38.0m

A commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases.

Seach Medical Group

Market Cap: ₪89.3m

Manufactures and sells medicinal cannabis products worldwide.

Compugen

Market Cap: ₪112.8m

A clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe.

Enlivex Therapeutics

Market Cap: ₪21.2m

Operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel.

Kamada

Market Cap: ₪1.3b

Manufactures and sells plasma-derived protein therapeutics.

Evogene

Market Cap: ₪25.1m

Operates as a computational biology company in Israel, the United States, Israel, Brazil, and internationally.

Rekah Pharmaceutical Industry

Market Cap: ₪131.3m

Engages in the manufacture, marketing, sale, and distribution of pharmaceuticals, cosmetics, vitamins and nutritional supplements, and medical devices in Israel.